AtaCor Medical Inc., founded in San Clemente, is a pioneering medical device company focused on transforming cardiac rhythm management. Their core mission is to innovate cardiac pacing solutions that minimize risks, costs, and drawbacks associated with traditional methods. AtaCor's flagship product, the AtaCor EV Temporary Pacing System, offers a novel approach to temporary cardiac pacing by delivering reliable and prompt pacing without the need to enter the heart, vascular system, or cath lab. This positions AtaCor at the forefront of the cardiac care market.

Notable figures affiliated with AtaCor Medical include experienced professionals in the medical device industry and investors who have recognized the potential of their groundbreaking technology. The company has achieved significant milestones, including successful clinical trials and regulatory approvals for their extravascular leads. AtaCor's innovations have had a substantial impact on the field of cardiac rhythm management, providing safer and more efficient pacing solutions for patients worldwide.